Advertisement

Soft Tissue Special Issue: Adamantinoma-Like Ewing Sarcoma of the Head and Neck: A Practical Review of a Challenging Emerging Entity

  • 14 Accesses

Abstract

Adamantinoma-like Ewing sarcoma (ALES) is a rare variant of Ewing sarcoma that is defined by complex epithelial differentiation, including expression of cytokeratin and p40 and frequent keratin pearl formation. In recent years, ALES has been increasingly recognized in the head and neck, where it can mimic a wide range of small round blue cell tumors and basaloid carcinomas. However, there has been persistent controversy regarding whether ALES is best classified and managed as a sarcoma or carcinoma. This review summarizes the characteristic clinical, pathologic, immunophenotypic, and molecular features of ALES with an emphasis on differential diagnosis and tumor classification.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang M, Walker C, et al. Adamantinoma-like Ewing’s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23(2):159–65.

  2. 2.

    Cruz J, Eloy C, Aragues JM, Vinagre J, Sobrinho-Simoes M. Small-cell (basaloid) thyroid carcinoma: a neoplasm with a solid cell nest histogenesis? Int J Surg Pathol. 2011;19(5):620–6.

  3. 3.

    Eloy C, Oliveira M, Vieira J, Teixeira MR, Cruz J, Sobrinho-Simoes M. Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case. Int J Surg Pathol. 2014;22(3):260–5.

  4. 4.

    Barroca H, Souto Moura C, Lopes JM, Lisboa S, Teixeira MR, Damasceno M, et al. PNET with neuroendocrine differentiation of the lung: report of an unusual entity. Int J Surg Pathol. 2014;22(5):427–33.

  5. 5.

    Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol. 2005;29(8):1025–33.

  6. 6.

    Fujii H, Honoki K, Enomoto Y, Kasai T, Kido A, Amano I, et al. Adamantinoma-like Ewing’s sarcoma with EWS-FLI1 fusion gene: a case report. Virchows Arch. 2006;449(5):579–84.

  7. 7.

    Alexiev BA, Tumer Y, Bishop JA. Sinonasal adamantinoma-like Ewing sarcoma: a case report. Pathol Res Pract. 2017;213(4):422–6.

  8. 8.

    Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39(9):1267–74.

  9. 9.

    Kikuchi Y, Kishimoto T, Ota S, Kambe M, Yonemori Y, Chazono H, et al. Adamantinoma-like Ewing family tumor of soft tissue associated with the vagus nerve: a case report and review of the literature. Am J Surg Pathol. 2013;37(5):772–9.

  10. 10.

    Lezcano C, Clarke MR, Zhang L, Antonescu CR, Seethala RR. Adamantinoma-like Ewing sarcoma mimicking basal cell adenocarcinoma of the parotid gland: a case report and review of the literature. Head Neck Pathol. 2015;9(2):280–5.

  11. 11.

    Lilo MT, Bishop JA, Olson MT, Ali SZ. Adamantinoma-like Ewing sarcoma of the parotid gland: cytopathologic findings and differential diagnosis. Diagn Cytopathol. 2018;46(3):263–6.

  12. 12.

    Weinreb I, Goldstein D, Perez-Ordonez B. Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome. Am J Surg Pathol. 2008;32(11):1742–8.

  13. 13.

    Mahadevan P, Ramkumar S, Gangadharan VP. Adamantinoma-Like Ewing’s family tumor of the sino nasal region: a case report and a brief review of literature. Case Rep Pathol. 2019;2019:6.

  14. 14.

    Morlote D, Harada S, Lindeman B, Stevens TM. Adamantinoma-Like Ewing sarcoma of the thyroid: a case report and review of the literature. Head Neck Pathol. 2019;13:618–23.

  15. 15.

    Ongkeko M, Zeck J, deBrito P. Molecular testing uncovers an adamantinoma-like ewing family of tumors in the thyroid: case report and review of literature. AJSP. 2018;23(1):8–12.

  16. 16.

    Rooper LM, Jo VY, Antonescu CR, Nose V, Westra WH, Seethala RR, et al. Adamantinoma-like Ewing sarcoma of the salivary glands: a newly recognized mimicker of basaloid salivary carcinomas. Am J Surg Pathol. 2019;43(2):187–94.

  17. 17.

    Fadul J, Bell R, Hoffman LM, Beckerle MC, Engel ME, Lessnick SL. EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma. Genes Cancer. 2015;6(3–4):129–43.

  18. 18.

    Hung YP, Fletcher CD, Hornick JL. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol. 2016;29(4):370–80.

  19. 19.

    Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch. 2014;465(5):599–605.

  20. 20.

    Collini P, Sampietro G, Bertulli R, Casali PG, Luksch R, Mezzelani A, et al. Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by molecular diagnostic studies. Am J Surg Pathol. 2001;25(2):273–4.

  21. 21.

    Gu M, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing’s sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol. 2000;24(3):410–6.

  22. 22.

    Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014;38(2):257–64.

  23. 23.

    Jo VY, Fletcher CD. p63 immunohistochemical staining is limited in soft tissue tumors. Am J Clin Pathol. 2011;136(5):762–6.

  24. 24.

    de Alava E, Lessnick SL, Sorenson PH. Ewing Sarcoma. In: Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO Classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer; 2013. p. 306–9.

  25. 25.

    Hauben E, van den Broek LC, Van Marck E, Hogendoorn PC. Adamantinoma-like Ewing’s sarcoma and Ewing’s-like adamantinoma. The t(11; 22), t(21; 22) status. J Pathol. 2001;195(2):218–21.

  26. 26.

    Solomon LW, Magliocca KR, Cohen C, Muller S. Retrospective analysis of nuclear protein in testis (NUT) midline carcinoma in the upper aerodigestive tract and mediastinum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):213–20.

  27. 27.

    Teo M, Crotty P, O’Sullivan M, French CA, Walshe JM. NUT midline carcinoma in a young woman. J Clin Oncol. 2011;29(12):e336–9.

  28. 28.

    Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, et al. NUT carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas. Am J Surg Pathol. 2018;42(7):877–84.

  29. 29.

    Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012;36(8):1216–21.

  30. 30.

    Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33(7):984–91.

  31. 31.

    Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, et al. SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol. 2017;41(4):458–71.

  32. 32.

    Agaimy A, Koch M, Lell M, Semrau S, Dudek W, Wachter DL, et al. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol. 2014;38(9):1274–81.

  33. 33.

    Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol. 2014;38(9):1282–9.

  34. 34.

    Dalin MG, Katabi N, Persson M, Lee KW, Makarov V, Desrichard A, et al. Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Nat Commun. 2017;8(1):1197.

  35. 35.

    Skalova A, Weinreb I, Hyrcza M, Simpson RH, Laco J, Agaimy A, et al. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol. 2015;39(3):338–48.

  36. 36.

    Faras F, Abo-Alhassan F, Hussain AH, Sebire NJ, Al-Terki AE. Primary desmoplastic small round cell tumor of upper cervical lymph nodes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(1):e4–10.

  37. 37.

    Mihok NA, Cha I. Desmoplastic small round cell tumor presenting as a neck mass: a case report. Diagn Cytopathol. 2001;25(1):68–72.

  38. 38.

    Pang B, Leong CC, Salto-Tellez M, Petersson F. Desmoplastic small round cell tumor of major salivary glands: report of 1 case and a review of the literature. Appl Immunohistochem Mol Morphol. 2011;19(1):70–5.

  39. 39.

    Wolf AN, Ladanyi M, Paull G, Blaugrund JE, Westra WH. The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation. Hum Pathol. 1999;30(4):430–5.

  40. 40.

    Dorfman DM, Shahsafaei A, Miyauchi A. Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation. Histopathology. 1998;32(2):104–9.

  41. 41.

    Kakudo K, Bai Y, Ozaki T, Homma K, Ito Y, Miyauchi A. Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): cD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid. Histol Histopathol. 2013;28(5):543–56.

  42. 42.

    Cheuk W, Jacobson AA, Chan JK. Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential. Mod Pathol. 2000;13(10):1150–5.

  43. 43.

    Folpe AL, Lloyd RV, Bacchi CE, Rosai J. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Am J Surg Pathol. 2009;33(8):1179–86.

  44. 44.

    Antonescu CR, Dal Cin P. Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours. Pathology. 2014;46(2):105–12.

  45. 45.

    Alassiri AH, Ali RH, Shen Y, Lum A, Strahlendorf C, Deyell R, et al. ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors. Am J Surg Pathol. 2016;40(8):1051–61.

  46. 46.

    Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18(2):184–7.

  47. 47.

    Kralik JM, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, et al. Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia. Diagn Pathol. 2011;6:19.

  48. 48.

    Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120(6):799–807.

  49. 49.

    Rubin BP, Chen CJ, Morgan TW, Xiao S, Grier HE, Kozakewich HP, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153(5):1451–8.

  50. 50.

    Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608.

  51. 51.

    Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2(5):367–76.

  52. 52.

    Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50(7):559–70.

  53. 53.

    Desmeules P, Joubert P, Zhang L, Al-Ahmadie HA, Fletcher CD, Vakiani E, et al. A subset of malignant mesotheliomas in young adults are associated with recurrent EWSR1/FUS-ATF1 fusions. Am J Surg Pathol. 2017;41(7):980–8.

  54. 54.

    Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom LG, Behrendtz M, et al. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2005;44(1):97–102.

  55. 55.

    Kao YC, Sung YS, Zhang L, Chen CL, Vaiyapuri S, Rosenblum MK, et al. EWSR1 fusions With CREB family transcription factors define a novel myxoid mesenchymal tumor with predilection for intracranial location. Am J Surg Pathol. 2017;41(4):482–90.

  56. 56.

    Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet. 1993;4(4):341–5.

  57. 57.

    Gradoni P, Giordano D, Oretti G, Fantoni M, Barone A, La Cava S, et al. Clinical outcomes of rhabdomyosarcoma and Ewing’s sarcoma of the head and neck in children. Auris Nasus Larynx. 2011;38(4):480–6.

  58. 58.

    Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348(8):694–701.

  59. 59.

    Huang M, Lucas K. Current therapeutic approaches in metastatic and recurrent ewing sarcoma. Sarcoma. 2011;2011:863210.

  60. 60.

    Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol. 2003;40(5):276–87.

Download references

Author information

Correspondence to Justin A. Bishop.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rooper, L.M., Bishop, J.A. Soft Tissue Special Issue: Adamantinoma-Like Ewing Sarcoma of the Head and Neck: A Practical Review of a Challenging Emerging Entity. Head and Neck Pathol (2020) doi:10.1007/s12105-019-01098-y

Download citation

Keywords

  • Ewing sarcoma
  • Adamantinoma-like Ewing sarcoma
  • EWSR1
  • FLI1
  • Complex epithelial differentiation